A double-blind, placebo-controlled investigation into the safety and efficacy of escitalopram for depression in multiple sclerosis
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression; Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2006 New trial record.